Entecavir 0.05 mg in 1 mL Oral Solution
RxNorm 485536
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 485536 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: entecavir 0.05 mg in 1 mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Entecavir 0.05 mg/ML Oral Solution
(Atom ID: 2078449)
PSNPrescribable
Prescribable Name (PSN):
Entecavir 0.05 mg in 1 mL Oral Solution
(Atom ID: 8253454)
SYPrescribable
Synonym (SY):
Entecavir 0.05 mg per 1 mL Oral Solution
(Atom ID: 8253455)
SYPrescribable
Synonym (SY):
Entecavir 50 mcg/ML Oral Solution
(Atom ID: 3802871)
PTPrescribable
Designated preferred name (PT):
Entecavir 50 microgram/mL oral solution
(Atom ID: 11436547)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely entecavir 50 microgram/1 mL conventional release oral solution (clinical drug)
(Atom ID: 11439782)
Patient Education
Entecavir
Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage. Entecavir is in a class of medications called nucleoside analogs. It works by decreasing the amount of hepatitis B virus (HBV) in the body. Entecavir does not cure HBV and may not prevent complications of chronic hepatitis B such as cirrhosis of the liver or liver cancer. Entecavir does not prevent the spread of HBV to other people.
[Learn More]
* Please review the disclaimer below.